Avantor, Inc. (AVTR)
14.20
-0.34
(-2.34%)
USD |
NYSE |
Sep 01, 16:00
14.22
+0.02
(+0.11%)
Pre-Market: 20:00
Avantor Cash from Operations (TTM) : 597.00M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 597.00M |
| March 31, 2026 | 573.20M |
| December 31, 2025 | 623.80M |
| September 30, 2025 | 644.40M |
| June 30, 2025 | 681.80M |
| March 31, 2025 | 808.50M |
| December 31, 2024 | 840.80M |
| September 30, 2024 | 919.10M |
| June 30, 2024 | 905.00M |
| March 31, 2024 | 792.10M |
| December 31, 2023 | 870.00M |
| September 30, 2023 | 824.00M |
| June 30, 2023 | 851.60M |
| March 31, 2023 | 910.90M |
| Date | Value |
|---|---|
| December 31, 2022 | 843.60M |
| September 30, 2022 | 939.00M |
| June 30, 2022 | 942.60M |
| March 31, 2022 | 978.90M |
| December 31, 2021 | 953.60M |
| September 30, 2021 | 958.60M |
| June 30, 2021 | 978.20M |
| March 31, 2021 | 803.60M |
| December 31, 2020 | 929.80M |
| September 30, 2020 | 710.80M |
| June 30, 2020 | 627.20M |
| March 31, 2020 | 532.10M |
| December 31, 2019 | 354.00M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Medpace Holdings, Inc. | 752.66M |
| Champions Oncology, Inc. | -4.472M |
| Personalis, Inc. | -92.30M |
| Adaptive Biotechnologies Corp. | -21.01M |
| 10X Genomics, Inc. | 127.08M |